Proteomic changes in hearts of kyphoscoliosis (ky) mutant mice in the absence of structural pathology: implication for the analysis of early human heart disease

Proteomics
Yanwen HouG R Coulton

Abstract

Complex molecular changes associated with early stage human heart disease are poorly understood and prevent the development of effective treatments of human cardiac disease. Relatively minor structural changes in early disease may accompany some conditions such as arrhythmias. Our objective was to determine if significant proteomic changes occur in heart tissues in the absence of structural pathology. We used a proteomic "pipeline" based on Ciphergen SELDI-TOF/MS, gel electrophoresis and MALDI-TOF/MS. The kyphoscoliosis (ky) mouse carries a mutation in a putative transglutaminase causing a primary skeletal muscle disease. The ky protein is expressed usually in skeletal and cardiac muscle but its absence from the ky heart causes no structural pathology making it a good model of "occult" heart disease. We discovered 20 statistically validated biomarkers discriminating ky from normal hearts, one cardiac troponin-I was reduced by 40% in ky hearts. A 17% deficit was confirmed subsequently by Western blot. Thus, the proteome of ky hearts was abnormal, giving support to our contention that this SELDI-based analytical approach is capable of making a significant contribution to the analysis of complex proteomic changes in early stage hu...Continue Reading

References

Feb 1, 1992·Muscle & Nerve·L R BridgesR M Mason
May 26, 1973·Lancet·A G Dickinson, V M Meikle
Feb 1, 1995·The American Journal of Physiology·G MaréchalG Beckers-Bleukx
Jul 1, 1996·British Journal of Clinical Pharmacology·D J NunezD Dutka
Nov 1, 1996·European Journal of Biochemistry·G MaréchalG Coulton
Jul 25, 2000·JAMA : the Journal of the American Medical Association·C A LabarrereH Halbrook
Oct 4, 2000·Physiological Genomics·D LynN L Emmett
Dec 8, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·E Bosimini
Mar 10, 2001·Cell·M T Keating, M C Sanguinetti
May 23, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·D JägerU Müller-Werdan
Aug 31, 2002·Nucleic Acids Research·Natalya BodyakAnny Usheva
Mar 14, 2003·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·John WeekesMichael J Dunn
Aug 21, 2003·Human Molecular Genetics·Emma McGregor, Michael J Dunn
Aug 26, 2003·Drug News & Perspectives·R T Lee
Sep 12, 2003·Journal of Molecular and Cellular Cardiology·Thomas M Vondriska, Peipei Ping
Oct 4, 2003·Circulation Research·Peipei Ping
Jun 9, 2004·Lancet·Perry Elliott, William J McKenna
Jul 16, 2004·Journal of Proteome Research·Eric C C YangK W Michael Siu
Sep 8, 2004·Proteomics·Marie-Catherine Le BihanGary R Coulton
Oct 19, 2004·Journal of the American College of Cardiology·W Robb MacLellanThomas Vondriska
Oct 27, 2004·Disease Markers·Brian A StanleyJennifer E Van Eyk
Aug 27, 2005·Proteomics·Sergei A MoshkovskiiAlexander I Archakov

❮ Previous
Next ❯

Citations

Sep 19, 2012·International Journal of Proteomics·George D WilsonJustin E Trivax
Jan 9, 2008·International Journal of Cardiology·Gengqian ZhangLin Zhang
Sep 1, 2007·Proteomics. Clinical Applications·José Bermúdez-Crespo, José Luis López
Jan 19, 2007·Molecular & Cellular Proteomics : MCP·Sven FratermanNeal A Rubinstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.